Wesley Research Institute

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• High blood pressure2 trials
• Pulmonary arterial hypertension2 trials
• Coeliac disease1 trial

Phase

• Phase 1/22 trials
• Phase 31 trial

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• GB002, Inc.1 trial
• Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA1 trial
• Pfizer1 trial

Closed trials

• Completed

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· Phase 3· GB002, Inc.· Source

• Completed

  A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

  NCT06137742· Phase 1/2· Pfizer· Source

• Terminated

  A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

  NCT05574010· Phase 1/2· Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA· Source